Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 1/2004

01-01-2004

Elevated transcript level of hyaluronan synthase1 gene correlates with poor prognosis of human colon cancer

Authors: Yoichi Yamada, Naoki Itano, Hisashi Narimatsu, Takashi Kudo, Kyoei Morozumi, Setsuo Hirohashi, Atsushi Ochiai, Minoru Ueda, Koji Kimata

Published in: Clinical & Experimental Metastasis | Issue 1/2004

Login to get access
Metadata
Title
Elevated transcript level of hyaluronan synthase1 gene correlates with poor prognosis of human colon cancer
Authors
Yoichi Yamada
Naoki Itano
Hisashi Narimatsu
Takashi Kudo
Kyoei Morozumi
Setsuo Hirohashi
Atsushi Ochiai
Minoru Ueda
Koji Kimata
Publication date
01-01-2004
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 1/2004
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/B:CLIN.0000017203.71293.e0

Other articles of this Issue 1/2004

Clinical & Experimental Metastasis 1/2004 Go to the issue

OriginalPaper

A novel assay for the quantification of invasion from raft cultures of lung carcinomas

OriginalPaper

p53 and HLA class-I expression are not down-regulated in colorectal cancer liver metastases

OriginalPaper

Measurement of tumor load and distribution in a model of cancer-induced osteolysis: A necessary precaution when testing novel anti-resorptive therapies

OriginalPaper

A systemic antitumor immune response prevents outgrowth of lung tumors after i.v. rechallenge but is not able to prevent growth of experimental liver tumors

OriginalPaper

Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients

OriginalPaper

Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits